Clinical study of the association of metabolic syndrome and obstructive sleep apnea in older patients
- Authors: Gosteva E.V.1, Kochetkova I.V.1, Brezhneva N.A.2, Kuptsov M.А.3
-
Affiliations:
- N.N. Burdenko Voronezh State Medical University
- Voronezh City Clinical Polyclinic No. 2
- Voronezh City Clinical Hospital of Emergency Medical Care No. 1
- Issue: Vol 29, No 1 (2026)
- Pages: 5-14
- Section: Original study articles
- Submitted: 14.01.2026
- Accepted: 31.03.2026
- Published: 16.04.2026
- URL: https://rjmseer.com/1560-9537/article/view/701000
- DOI: https://doi.org/10.17816/MSER701000
- EDN: https://elibrary.ru/ZINQGN
- ID: 701000
Cite item
Abstract
BACKGROUND: The relevance of the topic stems from the high comorbidity of metabolic syndrome and obstructive sleep apnea (OSA) in the older population, which increases the risk of cardiovascular complications and leads to the formation of a vicious circle.
AIM: To study the interrelationship between the components of metabolic syndrome and moderate obstructive sleep apnea in older patients.
METHODS: The study included 132 older patients (67.1 ± 2.9 years). Depending on the presence of abdominal obesity (AO) and OSA, four groups were formed: group 1, AO−/OSA− (32 participants); group 2, AO−/OSA+ (30 participants); group 3, AO+/OSA− (34 participants); and group 4, AO+/OSA+ (36 participants).
RESULTS: The most pronounced worsening of the metabolic profile was observed in older patients with comorbidity of AO and OSA: progression of insulin resistance (by HOMA-IR), deterioration of integral metabolic status (pronounced increase in TyG), and enhancement of the atherogenic dyslipidemic profile (increased triglycerides / low-density lipoprotein cholesterol). The highest blood pressure values and the greatest prevalence of circadian rhythm disturbances were found in AO+/OSA+ patients, indicating a more severe course of hypertension in this group compared with the others. Correlation analysis confirmed the high diagnostic efficacy of the TyG index as a marker of metabolic disorders in elderly patients (ρ = 0.847, p < 0.001).
CONCLUSION: The presented data suggest that the highest risk of metabolic disorders and the most severe course of arterial hypertension were observed in patients with comorbidity of abdominal obesity and moderate obstructive sleep apnea. The TyG index has high diagnostic accuracy for metabolic disorders in older patients.
Keywords
Full Text
About the authors
Elena V. Gosteva
N.N. Burdenko Voronezh State Medical University
Email: yanavrn@yandex.ru
ORCID iD: 0000-0002-8771-2558
SPIN-code: 6512-3585
MD, Dr. Sci. (Medicine), Associate Professor
Russian Federation, VoronezhIrina V. Kochetkova
N.N. Burdenko Voronezh State Medical University
Author for correspondence.
Email: iri4217@yandex.ru
ORCID iD: 0000-0002-7546-6679
SPIN-code: 9933-5015
MD, Cand. Sci. (Medicine), Associate Professor
Russian Federation, VoronezhNatalia A. Brezhneva
Voronezh City Clinical Polyclinic No. 2
Email: Natalia.brezhneva@gmail.com
ORCID iD: 0009-0002-0491-0127
Russian Federation, Voronezh
Mikhail А. Kuptsov
Voronezh City Clinical Hospital of Emergency Medical Care No. 1
Email: kuptsov-mikhail@yandex.ru
ORCID iD: 0009-0005-5156-4089
Russian Federation, Voronezh
References
- Buzunov RV, Palman AD, Melnikov AYu, et al. Diagnostics and treatment of obstructive sleep apnea syndrome in adults. Recommendations of the russian society of sleep medicine. Effective pharmacotherapy. 2018;(35):34–45. EDN: YNMYUP
- Surikova NA, Glukhova AS. Obstructive sleep apnea syndrome: literature review. CardioSomatics. 2023;14(1):67–76. doi: 10.17816/CS321374 EDN: MTMATB
- Rubina SS, Makarova II. Obstructive sleep apnea: a modern view of the problem. Ural Medical Journal. 2021;20(4):85–92. doi: 10.52420/2071-5943-2021-20-4-85-92 EDN: GFVDLR
- Agaltsov MV, Drapkina OM. The relationship of obstructive sleep apnea and cardiovascular diseases from the perspective of evidence — based medicine. Part 1. Cardiovascular Therapy and Prevention. 2020;19(3):102–107. doi: 10.15829/1728-8800-2020-2405 EDN: FECCID
- Osipova OA, Gosteva EV, Zhernakova NI, et al. 24-hour blood pressure profile and systemic inflammation in patients with stable coronary artery disease with obstructive sleep apnea. Cardiovascular Therapy and Prevention. 2023;22(9):69–76. doi: 10.15829/1728-8800-2023-3705 EDN: FFJJAW
- Anderson N, Tran P. Obstructive Sleep Apnea. Prim Care. 2025;52(1): 47–59. doi: 10.1016/j.pop.2024.09.007
- Buzunov RV. Obesity and Obstructive Sleep Apnea: How to Break the Vicious Circle. Effective Pharmacotherapy. 2020;16(2):30–33. doi: 10.33978/2307-3586-2020-16-2-30-33 EDN: JQJAZI
- Gorbunova MV, Babak SL, Malyavin AG. Modern Algorithm for the Diagnosis and Treatment of Cardiovascular and Metabolic Disorders in Patients with Obstructive Sleep Apnea. Lechebnoe delo. 2019;(1):20–29. doi: 10.24411/2071-5315-2019-12086 EDN: ZYRWAX
- Yang Y, Wu G, Ren L. Correlation between TG/HDL-C ratio and obstructive sleep apnea in the adult US population: a cross-sectional study. Front Neurol. 2025;16:1594875. doi: 10.3389/fneur.2025.1594875
- Zhou B, Yao Y, Wang Y, et al. Association Between Metabolic Score for Insulin Resistance (METS – IR) and Risk of Obstructive Sleep Apnea: Analysis of NHANES database and a Chinese cohort. Nat Sci Sleep. 2025;17:607–620. doi: 10.2147/NSS.S400125
- Li Y, Li H, Chen X, Liang X. Association between various insulin resistance indices and cardiovascular disease in middle-aged and elderly individuals: evidence from two prospectives nationwide cohort surveys. Front Endocrinol (Lausanne). 2024;15:1483468. doi: 10.3389/fendo.2024.1483468
- Osipova OA, Gosteva EV, Belousova ON. Metabolic risk factors in elderly patients depending on the presence of obstructive sleep apnea syndrome. Advances in Gerontology. 2022;35(6):927–932. doi: 10.34922/AE.2022.35.6.015 EDN: GOSGPE
- Mikhailova OO, Gogiberidze KO, Elfimova EM, et al Uncontrolled hypertension and obstructive sleep apnea: integrated treatment approach. Systemic Hypertension. 2022;19(3):41–47. doi: 10.38109/2075-082X-2022-3-41-47 EDN: MCAUMK
- Litvin АYu, Chazova IE, Elfimova EM, et al. Eurasian association of cardiology (EAC) / Russian society of somnologists (RSS) guidelines for the diagnosis and treatment of obstructive sleep apnea in patients with cardiovascular diseases (2024). Eurasian heart journal. 2024;(3):6–27. doi: 10.38109/2225-1685-2024-3-6-27 EDN: VOHDLA
- Amato MC, Giordano C. Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol. 2014;2014:730827. doi: 10.1155/2014/730827
- Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. doi: 10.1089/met.2008.0034
- Boytsov SA, Pogosova NV, Ansheles AA, et al. Cardiovascular prevention 2022. Russian national guidelines. Russian Journal of Cardiology. 2023;28(5):5452. doi: 10.15829/1560-4071-2023-5452 EDN: EUDWYG
- Brodovskaya TO, Kovin EA, Bazhenova OV, et al. Predictors of visceral obesity in normal weight obstructive sleep apnea patients. Obesity and metabolism. 2019;16(2):29–35. doi: 10.14341/omet9737 EDN: GIYCMW
- Libis RA, Isaeva EN. Opportunities for the use of visceral obesity index in metabolic syndrome diagnostics and prognosis of its complication risk. Russian Journal of Cardiology. 2014;(9):48–53. doi: 10.15829/1560-4071-2014-9-48-53 EDN: SMHCMX
- Demidova TYu, Izmaylova MYa, Belova KM. The role of triglyceride-glucose index in predicting cardiovascular and metabolic outcomes in patients with type 2 diabetes mellitus. Medical council. 2023;17(9):47–57. doi: 10.21518/ms2023-172 EDN: AROCKI
- Madyanov IV. Indirect methods for assessing insulin resistance in metabolic syndrome. RMJ. 2021;29(2):10–12. EDN: PLXWQO
- Wang C, Tan J, Miao Y, et al Obstructive sleep apnea, prediabetes and progression of type 2 diabetes: A systematic review and meta-analysis. J Diabetes Investig. 2022;13(8):1396–1411. doi: 10.1111/jdi.13793
Supplementary files

